ACCD / Down -31.39% in 4 Weeks, Here's Why Accolade (ACCD) Looks Ripe for a Turnaround

Accolade (ACCD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong more_horizontal

Accolade (ACCD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong more_horizontal

While Accolade increased revenue year over year, it is still losing money. Several analysts downgraded their price targets for the stock. more_horizontal

Accolade, Inc. (NASDAQ:ACCD ) Q2 2024 Earnings Conference Call October 4, 2023 4:30 PM ET Company Participants Todd Friedman - Senior Vice President, more_horizontal

Accolade (ACCD) came out with a quarterly loss of $0.43 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to loss of $0. more_horizontal

Accolade is in a good position to meet its revenue growth guidance for both the current fiscal year and long term. There is a risk that ACCD's bottom more_horizontal

SEATTLE, Sept. 06, 2023 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Sept. 5, 2023 by Accolade, Inc. (NASDAQ: ACCD), please note more_horizontal

Accolade is experiencing strong demand due to rising healthcare costs and employers seeking ways to reduce expenses. The company's proprietary technol more_horizontal